The mechanism: CMS pays Medicare Advantage plans a risk-adjusted rate per enrollee — sicker-coded members mean fatter checks from Washington. The agency's own estimate puts unsupported diagnosis coding at roughly $17 billion a year in overpayments, and CMS has now moved from auditing about 60 MA contracts annually to a plan that audits all ~550 eligible contracts, with sample sizes up to 200 records per plan instead of 35. A federal court vacated the extrapolation methodology CMS wanted to use to claw back money across a plan's whole membership, which caps near-term recoupment risk — but the audit volume increase is proceeding regardless, and it changes the coding-aggressiveness calculus for every plan going forward. The less a company's earnings depend on MA risk scores, the less this bites.
HUM vs. UNH: Who Wins If CMS Tightens Medicare Advantage Risk-Adjustment Audits
CMS is scaling RADV audits from roughly 60 Medicare Advantage plans a year to all ~550 eligible contracts — and the insurer whose earnings lean hardest on MA risk scores carries the biggest per-dollar downside.
The less a company's earnings depend on Medicare Advantage risk scores, the less this bites — and no major insurer depends on them more than Humana.
Who cashes in:
- UNH (UnitedHealth Group) — Medicare Advantage is a big book, but Optum's pharmacy (OptumRx), provider (Optum Health), and data/services segments generate earnings that don't run through the RADV audit trail at all. A stricter coding regime compresses the insurance segment's margin without touching the roughly half of enterprise profit that comes from Optum, giving UNH more room to absorb MA repricing without a proportional hit to consolidated earnings.
- ELV (Elevance Health) — Elevance's book skews more heavily to commercial and Medicaid managed care relative to Humana's MA concentration, and its CarelonRx/Carelon services arm provides the same kind of non-risk-adjusted earnings buffer that Optum gives UNH, just at smaller scale.
- CI (Cigna) — Cigna has largely exited individual MA in past years and is dominated by its Evernorth pharmacy-benefit and specialty-services business, which means it has structurally minimal exposure to MA risk-adjustment audit risk relative to peers — a name that benefits by simply not being in the blast radius.
- HCA (HCA Healthcare) — as the country's largest hospital operator, HCA is paid on DRGs and negotiated rates, not risk scores; if MA plans respond to audit pressure by coding more conservatively, that doesn't change what hospitals get paid for admissions, and any resulting friction between MA plans and patients over prior-auth/coding can indirectly push volume toward providers.
Who is exposed:
- HUM (Humana) — Humana is the most MA-concentrated major insurer in the industry, with the vast majority of its earnings tied directly to Medicare Advantage risk-adjusted premium. A stricter RADV regime — more contracts audited, larger samples, and continued pressure even after the extrapolation setback — compresses margin dollar-for-dollar in the one place Humana has the least diversification to absorb it.
- CNC (Centene) — Centene's book is concentrated in government-sponsored risk business (Medicaid managed care plus a growing MA and ACA book), so it shares the structural sensitivity to risk-adjustment methodology tightening, layered on top of its own Medicaid redetermination and rate pressures.
- CVS (CVS Health) — through Aetna, CVS carries meaningful MA exposure without an Optum-scale services offset, leaving it more exposed than UNH but somewhat less concentrated than Humana.
The play: This is a relative-value trade, not a binary one — the RADV expansion is a slow-moving audit pipeline (PY2018–2024 backlog, new audits roughly quarterly) rather than a single catalyst date. Watch each insurer's MA membership mix and risk-adjustment revenue disclosures in 10-Ks, CMS's audit cadence updates, and any appellate movement on the vacated extrapolation rule — a reversal there would sharpen the pain for the most MA-concentrated names fastest.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.